These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17477806)

  • 1. Possible therapeutic applications of single-chain antibodies in systemic autoimmune diseases.
    Angyal A; Prechl J; Sármay G
    Expert Opin Biol Ther; 2007 May; 7(5):691-704. PubMed ID: 17477806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunoglobulin, IgG Fc receptor and complement triangle in autoimmune diseases.
    Karsten CM; Köhl J
    Immunobiology; 2012 Nov; 217(11):1067-79. PubMed ID: 22964232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [B cell targeting therapy using the anti-CD20 antibody in autoimmune diseases].
    Tanaka Y
    Yakugaku Zasshi; 2009 Jun; 129(6):675-9. PubMed ID: 19483410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell-directed therapies for autoimmune disease and correlates of disease response and relapse.
    Levesque MC; St Clair EW
    J Allergy Clin Immunol; 2008 Jan; 121(1):13-21; quiz 22-3. PubMed ID: 18206502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders.
    Ballow M
    J Allergy Clin Immunol; 2011 Feb; 127(2):315-23; quiz 324-5. PubMed ID: 21185071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selfie: Autoimmunity, boon or bane.
    Ahsan H
    J Immunoassay Immunochem; 2017; 38(3):235-246. PubMed ID: 28421864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement Therapeutics in Autoimmune Disease.
    Thurman JM; Yapa R
    Front Immunol; 2019; 10():672. PubMed ID: 31001274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cells move to centre stage: novel opportunities for autoimmune disease treatment.
    Browning JL
    Nat Rev Drug Discov; 2006 Jul; 5(7):564-76. PubMed ID: 16816838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary immunodeficiency and autoimmunity: lessons from human diseases.
    Arason GJ; Jorgensen GH; Ludviksson BR
    Scand J Immunol; 2010 May; 71(5):317-28. PubMed ID: 20500682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complement system in systemic autoimmune disease.
    Chen M; Daha MR; Kallenberg CG
    J Autoimmun; 2010 May; 34(3):J276-86. PubMed ID: 20005073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New concepts in autoimmunity.
    Zanetti M
    Immunol Invest; 1986 May; 15(3):287-310. PubMed ID: 3093374
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug insight: the mechanism of action of rituximab in autoimmune disease--the immune complex decoy hypothesis.
    Taylor RP; Lindorfer MA
    Nat Clin Pract Rheumatol; 2007 Feb; 3(2):86-95. PubMed ID: 17299446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of Fc receptors on the development of autoimmune diseases.
    Kleinau S
    Curr Pharm Des; 2003; 9(23):1861-70. PubMed ID: 12871190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD20-depleting therapy in autoimmune diseases: from basic research to the clinic.
    Perosa F; Prete M; Racanelli V; Dammacco F
    J Intern Med; 2010 Mar; 267(3):260-77. PubMed ID: 20201920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement as a Therapeutic Target in Systemic Autoimmune Diseases.
    Galindo-Izquierdo M; Pablos Alvarez JL
    Cells; 2021 Jan; 10(1):. PubMed ID: 33451011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cells in health and disease.
    Carter RH
    Mayo Clin Proc; 2006 Mar; 81(3):377-84. PubMed ID: 16529141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cells as a therapeutic target in autoimmune diseases.
    Park YW; Pryshchep S; Seyler TM; Goronzy JJ; Weyand CM
    Expert Opin Ther Targets; 2005 Jun; 9(3):431-45. PubMed ID: 15948665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell-directed therapy for inflammatory skin diseases.
    Nagel A; Hertl M; Eming R
    J Invest Dermatol; 2009 Feb; 129(2):289-301. PubMed ID: 19148218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunomodulation therapy for autoimmune diseases. New hope for patients with autoimmune diseases].
    Szegedi G
    Orv Hetil; 2005 Apr; 146(14):635-43. PubMed ID: 15889537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role and clinical implications of G6PI in experimental models of rheumatoid arthritis.
    Kamradt T; Schubert D
    Arthritis Res Ther; 2005; 7(1):20-8. PubMed ID: 15642150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.